These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28187030)

  • 1. Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine. Part 3: Technical Validation of Immunohistochemistry (IHC) Assays in Clinical IHC Laboratories.
    Torlakovic EE; Cheung CC; D'Arrigo C; Dietel M; Francis GD; Gilks CB; Hall JA; Hornick JL; Ibrahim M; Marchetti A; Miller K; van Krieken JH; Nielsen S; Swanson PE; Vyberg M; Zhou X; Taylor CR;
    Appl Immunohistochem Mol Morphol; 2017 Mar; 25(3):151-159. PubMed ID: 28187030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 4: Tissue Tools for Quality Assurance in Immunohistochemistry.
    Cheung CC; D'Arrigo C; Dietel M; Francis GD; Fulton R; Gilks CB; Hall JA; Hornick JL; Ibrahim M; Marchetti A; Miller K; van Krieken JH; Nielsen S; Swanson PE; Taylor CR; Vyberg M; Zhou X; Torlakovic EE;
    Appl Immunohistochem Mol Morphol; 2017 Apr; 25(4):227-230. PubMed ID: 27941560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 1: Fit-for-Purpose Approach to Classification of Clinical Immunohistochemistry Biomarkers.
    Cheung CC; D'Arrigo C; Dietel M; Francis GD; Gilks CB; Hall JA; Hornick JL; Ibrahim M; Marchetti A; Miller K; van Krieken JH; Nielsen S; Swanson PE; Taylor CR; Vyberg M; Zhou X; Torlakovic EE;
    Appl Immunohistochem Mol Morphol; 2017 Jan; 25(1):4-11. PubMed ID: 27922482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance Characteristics.
    Torlakovic EE; Cheung CC; D'Arrigo C; Dietel M; Francis GD; Gilks CB; Hall JA; Hornick JL; Ibrahim M; Marchetti A; Miller K; van Krieken JH; Nielsen S; Swanson PE; Vyberg M; Zhou X; Taylor CR;
    Appl Immunohistochem Mol Morphol; 2017 Feb; 25(2):79-85. PubMed ID: 28182587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General Guidelines for Quality Assurance of Immunohistochemistry in a Mohs Lab.
    Kinas CG; Carroll BT
    Dermatol Surg; 2017 Apr; 43(4):507-511. PubMed ID: 28359076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytic Validation of Immunohistochemistry Assays: New Benchmark Data From a Survey of 1085 Laboratories.
    Stuart LN; Volmar KE; Nowak JA; Fatheree LA; Souers RJ; Fitzgibbons PL; Goldsmith JD; Astles JR; Nakhleh RE
    Arch Pathol Lab Med; 2017 Sep; 141(9):1255-1261. PubMed ID: 28557616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Call for a European programme in external quality assurance for bone marrow immunohistochemistry; report of a European Bone Marrow Working Group pilot study.
    Torlakovic EE; Naresh K; Kremer M; van der Walt J; Hyjek E; Porwit A
    J Clin Pathol; 2009 Jun; 62(6):547-51. PubMed ID: 19474355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Consortium for Analytic Standardization in Immunohistochemistry.
    Bogen SA; Dabbs DJ; Miller KD; Nielsen S; Parry SC; Szabolcs MJ; t'Hart N; Taylor CR; Torlakovic EE
    Arch Pathol Lab Med; 2022 May; 147(5):584-590. PubMed ID: 36084252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External quality assessment for immunohistochemistry: experiences from NordiQC.
    Nielsen S
    Biotech Histochem; 2015 Jul; 90(5):331-40. PubMed ID: 25901597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemistry validation procedures and practices: a College of American Pathologists survey of 727 laboratories.
    Hardy LB; Fitzgibbons PL; Goldsmith JD; Eisen RN; Beasley MB; Souers RJ; Nakhleh RE
    Arch Pathol Lab Med; 2013 Jan; 137(1):19-25. PubMed ID: 23276171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing ALK Immunohistochemistry and In Situ Hybridization Proficiency Testing for Non-Small Cell Lung Cancer in Canada: Canadian Immunohistochemistry Quality Control Challenges and Successes.
    Cheung CC; Garratt J; Won J; Cutz JC; Gilks BC; Tsao M; Torlakovic EE
    Appl Immunohistochem Mol Morphol; 2015; 23(10):677-81. PubMed ID: 26551338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of molecular diagnostic assays and quality assurance and control in the veterinary laboratory.
    Saunders N; Sharp I
    Methods Mol Biol; 2015; 1247():77-105. PubMed ID: 25399089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proficiency testing in immunohistochemistry--experiences from Nordic Immunohistochemical Quality Control (NordiQC).
    Vyberg M; Nielsen S
    Virchows Arch; 2016 Jan; 468(1):19-29. PubMed ID: 26306713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemistry practices of cytopathology laboratories: a survey of participants in the College of American Pathologists Nongynecologic Cytopathology Education Program.
    Fischer AH; Schwartz MR; Moriarty AT; Wilbur DC; Souers R; Fatheree L; Booth CN; Clayton AC; Kurtyz DF; Padmanabhan V; Crothers BA
    Arch Pathol Lab Med; 2014 Sep; 138(9):1167-72. PubMed ID: 24840035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory compliance with the American Society of Clinical Oncology/College of American Pathologists human epidermal growth factor receptor 2 testing guidelines: a 3-year comparison of validation procedures.
    Dyhdalo KS; Fitzgibbons PL; Goldsmith JD; Souers RJ; Nakhleh RE
    Arch Pathol Lab Med; 2014 Jul; 138(7):876-84. PubMed ID: 24978913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Avoiding pitfalls in diagnostic immunohistochemistry-important technical aspects that every pathologist should know.
    Miller RT
    Semin Diagn Pathol; 2019 Sep; 36(5):312-335. PubMed ID: 31227425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Audit of Failed Immunohistochemical Slides in a Clinical Laboratory: The Role of On-Slide Controls.
    Cheung CC; Taylor CR; Torlakovic EE
    Appl Immunohistochem Mol Morphol; 2017; 25(5):308-312. PubMed ID: 26657875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Digitalization and multiplex IHC as predictive biomarkers for novel immune-therapeutics : New challenges for immunohistochemistry].
    Zielinski D
    Pathologe; 2019 May; 40(3):256-263. PubMed ID: 31089796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of Immunohistochemical Assays for Integral Biomarkers in the NCI-MATCH EAY131 Clinical Trial.
    Khoury JD; Wang WL; Prieto VG; Medeiros LJ; Kalhor N; Hameed M; Broaddus R; Hamilton SR
    Clin Cancer Res; 2018 Feb; 24(3):521-531. PubMed ID: 28839110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of TMA for interlaboratory validation of FISH testing for detection of HER2 gene amplification in breast cancer.
    Diaz LK; Gupta R; Kidwai N; Sneige N; Wiley EL
    J Histochem Cytochem; 2004 Apr; 52(4):501-7. PubMed ID: 15034001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.